Autopsy report · NCT03186911

The Impact of E-liquid Nicotine Content on Reinforcement in Current Smokers

“Study team decided not to move forward with study”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Wake Forest University Health Sciences

Sponsor type

University, hospital or other

Conditions

Tobacco Use

Interventions

E-liquid sampling and preference assessment

Participants

0

Trials that died the same way

• Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer
  “Study never moved forward due to no accrual” (78% match in meaning)
• Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
  “Decision was made to not go forward with the study” (77% match in meaning)
• Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation
  “Investigator decided not to move forward with study prior to study start date” (77% match in meaning)
• Hemostasis in Kocher-Langenbeck Approaches for Acetabular Surgery Using a Topical Surgical Hemostat (Vitagel)
  “Study team left institution; no one remaining to finish study” (74% match in meaning)
• Dynamic Motor Cortical Responses to Subdural Electrical Stimulation.
  “Study team is no longer moving forward with this study.” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.